mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.4 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |